← Leaderboards
Michael B Sporn
Dartmouth College
$8,497,060
Attributed
$8,497,060
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $713.8K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,497,060 · 6
By mechanism
R01$7,423,398 · 2
R43$949,702 · 2
R03$120,960 · 1
R13$3,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Dartmouth College
Same institution · by research overlap
- Ethan Dmitrovsky$11,142,103
- Li Lily Wang$7,371,035
- Keith D. Paulsen$38,192,657
Others in their field
Top investigators on “Chemoprevention”
- Charles A Coltman · Southwest Oncology Group$144,723,158
- Norman Wolmark · Nsabp Foundation, Inc.$110,141,959
- John Anthony Baron · Dartmouth College$61,176,184
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- Caroline C Sigman · Ccs Associates, Inc.$26,419,788
- Jonathan White · Midwest Research Institute$24,635,824
Research focus
ChemopreventionCancer PreventionLaboratory MouseNeoplastic CellCell LineEnzyme Induction /RepressionPharmaceutical PreparationsDrug Screening /EvaluationPreventMolecular TargetGenetic Promoter ElementNitric Oxide SynthaseChemopreventive AgentMalignant NeoplasmsProstaglandin Endoperoxide SynthaseDrug Design /Synthesis /ProductionChemical SynthesisInduction Of ApoptosisAnimal ModelInvestigationApoptoticApoptosisGenesMediating
Grant awards (28)
Development of the New Synthetic Triterpenoid CDDO-2P-IM (TTX01) for Glioblastoma$399,908
R43 · FY2020 · CA · contact PI
Development of the New Synthetic Triterpenoid CDDO-2P-Im for Chemoprevention of the ARDS of COVID-19$249,799
R43 · FY2020 · CA · contact PI
Development of the New Synthetic Triterpenoid CDDO-2P-IM (TTX01) for Multiple Myeloma$299,995
R43 · FY2019 · CA · contact PI
New Triterpenoids for Chemoprevention and Therapy of Cancer$320,375
R01 · FY2013 · CA · contact PI
New Triterpenoids for Chemoprevention and Therapy of Cancer$340,825
R01 · FY2012 · CA · contact PI
New Triterpenoids for Chemoprevention and Therapy of Cancer$340,825
R01 · FY2011 · CA · contact PI
New Triterpenoids for Chemoprevention and Therapy of Cancer$351,366
R01 · FY2010 · CA · contact PI
New Triterpenoids for Chemoprevention and Therapy of Cancer$351,366
R01 · FY2009 · CA · contact PI
New Triterpenoids for Cancer Chemoprevention & Therapy$341,132
R01 · FY2008 · CA · contact PI
New Triterpenoids for Cancer Chemoprevention & Therapy$341,132
R01 · FY2007 · CA · contact PI
Chemoprevention of Estrogen Receptor Negative Breast Cancer$333,333
R01 · FY2007 · CA · contact PI
New Triterpenoids for Cancer Chemoprevention & Therapy$351,320
R01 · FY2006 · CA · contact PI
Chemoprevention of ER-Negative Breast Cancer$343,288
R01 · FY2006 · CA · contact PI
New Triterpenoids for Cancer Chemoprevention &Therapy$359,213
R01 · FY2005 · CA
Chemoprevention of ER-Negative Breast Cancer$351,550
R01 · FY2005 · CA
Conference on Roles of TGF-Beta in Disease Pathogenesis$3,000
R13 · FY2005 · CA
New Triterpenoids for Cancer Chemoprevention and Therapy$357,075
R01 · FY2004 · CA
Chemoprevention of ER-Negative Breast Cancer$351,550
R01 · FY2004 · CA
NEW TRITERPENOIDS FOR CHEMOPREVENTION OF CANCER$740,752
R01 · FY2003 · CA
Chemoprevention of ER-Negative Breast Cancer$351,550
R01 · FY2003 · CA
NEW TRITERPENOIDS FOR CHEMOPREVENTION OF CANCER$370,562
R01 · FY2002 · CA
PPARy, a molecular Target for Prevention of Cancer$362,789
R01 · FY2002 · CA
NEW TRITERPENOIDS FOR CHEMOPREVENTION OF CANCER$50,000
R01 · FY2002 · CA
NEW TRITERPENOIDS FROM INDIAN PLANTS TO PREVENT CANCER$40,320
R03 · FY2002 · TW
NEW TRITERPENOIDS FOR CHEMOPREVENTION OF CANCER$361,229
R01 · FY2001 · CA
NEW TRITERPENOIDS FROM INDIAN PLANTS TO PREVENT CANCER$40,320
R03 · FY2001 · TW
NEW TRITERPENOIDS FOR CHEMOPREVENTION OF CANCER$352,166
R01 · FY2000 · CA
NEW TRITERPENOIDS FROM INDIAN PLANTS TO PREVENT CANCER$40,320
R03 · FY2000 · TW